Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Objectives: To assess the effect of vitamin D supplementation on bone mineral density (BMD) in rheumatoid arthritis (RA) patients with osteoporosis and determine whether supplementation of more than 800 IU/day, which is the currently recommended dose, is beneficial.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were classified into four groups according to the dosage of vitamin D supplementation, which were as follows: 0, 400, 800, and ≥1,000 IU/day.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis
Study design awaiting verification · Frontiers in Medicine · 2020
Original publication title
Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis
Copyright © 2020 Kwon, Oh, Park and Kim.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To assess the effect of vitamin D supplementation on bone mineral density (BMD) in rheumatoid arthritis (RA) patients with osteoporosis and determine whether supplementation of more than 800 IU/day, which is the currently recommended dose, is beneficial.
Source: Objectives:Abstract: What methods does the paper describe?
RA patients with osteoporosis who received bisphosphonate were included. Patients were classified into four groups according to the dose of vitamin D supplementation (0, 400, 800, and ≥1,000 IU/day). Multivariable linear regression models were performed to evaluate the effect of each dose of vitamin D supplementation on 1-year% change of BMD.
Source: Methods:Abstract: Results
In total, 187 RA patients with osteoporosis were included. In the multivariate model adjusted for potential confounders, patients receiving vitamin D supplementation had a significantly higher increase in 1-year % change in lumbar spine BMD (400 IU/day: β = 2.51 [95% CI: 0.04 to 4.99], 800 IU/day: β = 2.90 [95% CI: 0.47 to 5.33], and ≥1,000 IU/day: β = 6.01 [95% CI: 3.71 to 8.32]) and femoral neck BMD (400 IU/day: β = 3.88 [95% CI: 1.83 to 5.94], 800 IU/day: β =4.30 [95% CI: 2.25 to 6.35], and ≥1,000 IU/day: β = 6.79 [95% CI: 4.87 to 8.71]) than those not receiving the supplementation. Notably, the ≥1,000-IU/day group had a significantly higher increase in 1-year % change in lumbar spine BMD (β = 3.11 [95% CI: 0.86 to 5.37]) and femoral neck BMD (β = 2.50 [95% CI: 0.63 to 4.36]) than the 800-IU/day group.
Source: Results:Abstract: Conclusion
In RA patients with osteoporosis receiving bisphosphonates, vitamin D supplementation was associated with a higher increase in BMD. This effect was higher in the vitamin D supplementation dose of ≥1,000 IU/day than in 800 IU/day.
Source: Conclusion:Authors’ abstract
Objectives:
To assess the effect of vitamin D supplementation on bone mineral density (BMD) in rheumatoid arthritis (RA) patients with osteoporosis and determine whether supplementation of more than 800 IU/day, which is the currently recommended dose, is beneficial.
Methods:
RA patients with osteoporosis who received bisphosphonate were included. Patients were classified into four groups according to the dose of vitamin D supplementation (0, 400, 800, and ≥1,000 IU/day). Multivariable linear regression models were performed to evaluate the effect of each dose of vitamin D supplementation on 1-year% change of BMD.
Results:
In total, 187 RA patients with osteoporosis were included. In the multivariate model adjusted for potential confounders, patients receiving vitamin D supplementation had a significantly higher increase in 1-year % change in lumbar spine BMD (400 IU/day: β = 2.51 [95% CI: 0.04 to 4.99], 800 IU/day: β = 2.90 [95% CI: 0.47 to 5.33], and ≥1,000 IU/day: β = 6.01 [95% CI: 3.71 to 8.32]) and femoral neck BMD (400 IU/day: β = 3.88 [95% CI: 1.83 to 5.94], 800 IU/day: β =4.30 [95% CI: 2.25 to 6.35], and ≥1,000 IU/day: β = 6.79 [95% CI: 4.87 to 8.71]) than those not receiving the supplementation. Notably, the ≥1,000-IU/day group had a significantly higher increase in 1-year % change in lumbar spine BMD (β = 3.11 [95% CI: 0.86 to 5.37]) and femoral neck BMD (β = 2.50 [95% CI: 0.63 to 4.36]) than the 800-IU/day group.
Conclusion:
In RA patients with osteoporosis receiving bisphosphonates, vitamin D supplementation was associated with a higher increase in BMD. This effect was higher in the vitamin D supplementation dose of ≥1,000 IU/day than in 800 IU/day.
Publication and source details
Original title: Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis
Oh Chan Kwon; Ji Seon Oh; Min-Chan Park; Yong-Gil Kim
Frontiers in Medicine · 2020
Edited by: Barbara Ruaro, Centro Cardinal Ferrari, Italy
Reviewed by: Mario Salazar-Paramo, University of Guadalajara, Mexico; Xavier Noguès, Université de Bordeaux, France; José Antonio P. Da Silva, University of Coimbra, Portugal
This article was submitted to Rheumatology, a section of the journal Frontiers in Medicine
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T02:33:28.011941+00:00
DOI: 10.3389/fmed.2020.00443 · PMC7473387